Demyelinating Neurological Adverse Events following the Use of Anti-TNF-α Agents: A Double-Edged Sword

Demyelinating Neurological Adverse Events following the Use of Anti-TNF-α Agents: A Double-Edged Sword

Background. Tumor necrosis factor antagonists (anti-TNF-α) are an established therapeutic option for several autoimmune and inflammatory bowel diseases. Despite their clinical effectiveness, neurological adverse events have been reported, and literature data suggest a potential role of anti-TNF-α in...

Full description

Saved in:
Bibliographic Details
Main Authors: Miral H. Gharib, Mohamed Awni AlKahlout, Beatriz Garcia Canibano, Dirk Theophiel Deleu, Hani Malallah AlEssa, Samar AlEmadi
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Case Reports in Neurological Medicine
Online Access:http://dx.doi.org/10.1155/2022/3784938
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items